Rondo Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Rondo Therapeutics?

Rondo Therapeutics has 5 investors including SV Health Investors And Johnson & Johnson Innovation.

Q: How much funding has Rondo Therapeutics raised to date?

Rondo Therapeutics has raised obfuscated.

Overview

Rondo Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Rondo Therapeutics

CB Rank

23563

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

Founded

obfuscation

Private

Series A

Hayward, California, United States

11-50

www.rondotx.com

Biopharma

Biotechnology

Health Care

Life Science

Funding Rounds

Series A

OBF

obfuscation

Key People

Todd Meyerrose: Investor
Shelley Force Aldred: Founder & CEO
Past Role: SwitchGear Genomics, Co-Founder & COO

Details

Legal Name

Rondo Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Nathan Trinklein, Shelley Force Aldred

About the Company

Rondo Therapeutics is a therapeutic antibody discovery and development that creates novel bispecific antibodies that activate the immune system to fight cancer. The company was founded in 2021 and is headquartered in Hayward, California.

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Partnership Announcements

Products & Services

RNDO-564

A bispecific antibody targeting CD28 and Nectin-4 for treating solid tumors such as bladder, head & neck, and non-small cell lung cancers.

RNDO-Program 2

Bispecific antibodies targeting CD3 or CD28 paired with undisclosed tumor antigens for ovarian cancer treatment, in IND enabling stage.

Research & Development

Rondo Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A
obfuscated obfuscation	Series A - Rondo Therapeutics	5	obfuscated obfuscation	Canaan Partners, Red Tree Venture Capital	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
SV Health Investors	—	Series A - Rondo Therapeutics	—
SV Health Investors	—	Series A - Rondo Therapeutics	—
SV Health Investors	—	Series A - Rondo Therapeutics	—
SV Health Investors	—	Series A - Rondo Therapeutics	—
SV Health Investors	—	Series A - Rondo Therapeutics	—